AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
New Grok Imagine limits spark user fury: Continues glitch or policy shift?
2
Israeli startup Thermagix claims “the only economical solution for harvesting low-grade heat”
3
Oasis Security raises $120 million Series B to secure the rise of AI agents
4
Former Mossad chief and real estate tycoons back controversial Israeli drone company
5
Israel’s war with Iran costs up to $550 million a day
More news

CEO

7 stories about CEO
גבי זליגסון מנכ"ל קורנית דיגיטל

HP Veteran to Replace CEO of Israel-Based Industrial Printer Company Kornit

05.06.18|Dror Reich
Ronen Samuel, former head of HP Indigo, will take office in August after current CEO Gabi Seligsohn steps down
בועז דינטי Qumra Venture Capital

The Skills That Successful CEOs Share with Triathlon Athletes

23.04.18|Boaz Dinte
As a veteran venture capitalist and Ironman competitor, Boaz Dinte believes that running a successful company is much like competing in sports
הדמיה רובוט מגל מערכות

Security Contractor Magal Appoints New CEO

12.04.18|Amarelle Wenkert
Dror Sharon is set to replace Saar Koursh, who was appointed CEO in 2015
ליעם גלין נשיא מנכ"ל מטומי

Digital Marketing Company Matomy Media Replaces CEO after Ten Months

09.01.18|Lilach Baumer
Current CEO Sagi Niri has carried out a reorganization plan in 2017, selling non-core assets and streamlining the company's operations
המדען הראשי ב כלל ביוטכנולוגיה ד"ר ג'וליאן אדמס

Pharma Veteran Julian Adams takes Helm at Gamida Cell

21.11.17|Lilach Baumer
The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor
מנכ"ל טבע החדש קור שולץ 2

New Teva CEO Kåre Schultz to Relocate to Israel

17.10.17|Golan Hazani
Mr. Schultz, who led Copenhagen-based H. Lundbeck A/S since 2015, will come to Israel and assume his new position by the end of the month
קור שולץ מנכ"ל טבע החדש

Teva Appoints Lundbeck's Schultz as CEO

11.09.17|Dror Reich and Micky Grunfeld
The company’s announcement brings an end to a seven month search for a CEO to lead the troubled generic drugmaker. Updated
Previous Articles